2026 ACC/AHA multisociety guideline on the management of dyslipidemia

The 2026 guideline from the American College of Cardiology and the American Heart Association, with other societies named in its title, on managing dyslipidemia: high blood cholesterol, high triglycerides and elevated lipoprotein(a). Its abstract says it replaces the 2018 guideline on blood cholesterol. Only the abstract could be read, so this page gives no thresholds, targets or recommendations.

Also called 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

  • Guideline
  • In this atlas

Overview

Technical summary

Circulation 2026;153(17):e1154-e1276, doi 10.1161/CIR.0000000000001423, PMID 41824552. Electronic publication 2026-03-13. Issued by the joint ACC/AHA committee on clinical practice guidelines. The title names nine more societies by abbreviation; the abbreviations alone do not tie them to records in this atlas, so only the ACC and the AHA are linked as issuers. The abstract does not name the risk equation the guideline uses. PubMed lists two corrections (2026-06-23 and 2026-09-08); their text was not read.

About this guideline

Edition
2026 guideline
Published
2026-03-13
Status
Not checked for a newer edition
Scope
Evaluation, management and monitoring of individuals with high blood cholesterol, high triglycerides and elevated lipoprotein(a).

Source

Document
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Publisher
Circulation
Edition note
Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it.

Recommendations

No recommendation in this atlas names this guideline yet.

Claims and evidence

Context Individuals with dyslipidemia (2026 ACC/AHA multisociety guideline)

Recipient
Recipient not specified
Population
Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.
Care setting
Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.
Geography
Not stated in the abstract (issued by American societies; jurisdiction not verified)
Life stage
Not stated in the abstract
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (guideline context)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Individuals with high blood cholesterol, high triglycerides or elevated lipoprotein(a), as the abstract describes the focus
Excluded
None stated
  • Description Guidance Certainty not assessed

    The abstract of the 2026 ACC/AHA multisociety dyslipidemia guideline says it retires and replaces the 2018 guideline on managing blood cholesterol. It says the guideline addresses evaluation, management and monitoring of people with high blood cholesterol, high triglycerides and elevated lipoprotein(a).

    Source problem. A cited source is corrected. Check the sources before relying on this claim.

    Applies to Recipient not specified
    • Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.
    • Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.
    • Not stated in the abstract (issued by American societies; jurisdiction not verified)
    • Not stated in the abstract
    • Gestational age Not reported
    • Postnatal age Not reported
    Follow-up Not applicable (guideline context)
    Certainty method
    Not assessed
    Limitations
    Only the abstract and the bibliographic record were read, so no threshold, target, medicine or class of recommendation from the guideline is recorded. PubMed lists two corrections to the guideline (2026-06-23 and 2026-09-08); their text was not read, so it is not known whether they change anything the abstract says. This claim states the replacement. It does not link to a record of the 2018 guideline.
    Last checked
    2026-10-15
    Next evidence check due
    Not scheduled
    Sources and citations (3)
    1. Supports 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

      Guideline · Circulation · Edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it. · Published 2026-04-28 · DOI: 10.1161/CIR.0000000000001423 · PMID: 41824552

      Locator
      Abstract, AIM
      How it applies
      The guideline retires and replaces the 2018 blood cholesterol guideline.
      Retrieved
      Source effective date
      Not reported
      Source state
      Corrected
      Snapshot hash
      afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff
      Reuse basis
      PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.
    2. Supports 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

      Guideline · Circulation · Edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it. · Published 2026-04-28 · DOI: 10.1161/CIR.0000000000001423 · PMID: 41824552

      Locator
      Abstract, STRUCTURE, sentence 1
      How it applies
      What the guideline addresses.
      Retrieved
      Source effective date
      Not reported
      Source state
      Corrected
      Snapshot hash
      afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff
      Reuse basis
      PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.
    3. Background 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

      Guideline · Circulation · Edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it. · Published 2026-04-28 · DOI: 10.1161/CIR.0000000000001423 · PMID: 41824552

      Locator
      CommentsCorrectionsList, two ErratumIn entries
      How it applies
      Shows that corrections exist. What they change is unknown.
      Retrieved
      Source effective date
      Not reported
      Source state
      Corrected
      Snapshot hash
      afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff
      Reuse basis
      PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. Public text is quote under the PubMed abstract rule: only short quotations from the PubMed abstract, with attribution.

Record details

Record id
cardio:guideline-acc-aha-2026-dyslipidemia
Content hash
ea5fdbd01fe6c7ab0ac2a46d43a4ef33d5bea8ef7ca85dfb7b7c845ce0768068